Mirae Asset Global Investments
OBIO icon

Mirae Asset Global Investments’s Orchestra BioMed OBIO Stock Holding History

Mirae Asset Global Investments’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.6K Sell
2,678
-267
-9% -$1.09K ﹤0.01% 1555
2026
Q1 		$12.5K Buy
2,945
+201
+7% +$856 ﹤0.01% 1480
2025
Q4 		$11.4K Buy
+2,744
New +$11.1K ﹤0.01% 1592

Other funds holding OBIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $137M AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HIW
Holos Integrated Wealth Kennett Square, Pennsylvania $214M AUM 14.99% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Mirae Asset Global Investments's OBIO Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Orchestra BioMed (OBIO) stake by 9.1% in Q2 2026, selling an estimated $1.09K and leaving 2,678 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1555.

Mirae Asset Global Investments first reported a position in OBIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $12.5K in Q1 2026. 25 funds tracked by Wall St. Rank hold OBIO as of Q2 2026.

  • Mirae Asset Global Investments held 2,678 shares of Orchestra BioMed worth $11.6K as of Q2 2026.
  • Mirae Asset Global Investments sold 267 Orchestra BioMed shares in Q2 2026, an estimated $1.09K.
  • Orchestra BioMed made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1555 holding.
  • Mirae Asset Global Investments first reported a position in Orchestra BioMed in Q4 2025 and has held it in 3 quarters since.
  • Mirae Asset Global Investments's Orchestra BioMed position peaked at $12.5K in Q1 2026.
  • 25 funds tracked by Wall St. Rank held Orchestra BioMed as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.